Varex Imaging (VREX) Stock Price, News & Analysis

Company Overview

Varex Imaging Corporation is a global provider of X-ray imaging components and solutions for the medical, security and industrial markets. The company designs, develops and manufactures a broad range of products that convert X-ray energy into high-resolution digital images. Its portfolio includes X-ray tubes, flat panel detectors, digital sensors, specialty radiographic tubes and related software, all engineered to meet the demanding requirements of original equipment manufacturers (OEMs) in diagnostic imaging, computed tomography (CT), fluoroscopy, mammography, dental radiography and non-destructive testing applications.

The company’s medical imaging offerings support a wide spectrum of clinical modalities, from portable radiography systems to advanced CT scanners, enhancing image quality and dose efficiency for healthcare providers. In the security arena, Varex Imaging supplies detector solutions for baggage and cargo screening systems used in airports, border crossings and critical infrastructure. Its industrial imaging products enable inspections in aerospace, automotive and manufacturing sectors, where reliable detection of material defects is critical for safety and quality assurance.

Varex Imaging was established in August 2017 as an independent, publicly traded company following the separation of the imaging components business from Varian Medical Systems. Building on decades of heritage tracing back to Varian Associates, the company has leveraged its expertise to expand manufacturing and research capabilities across multiple sites in North America, Europe and Asia. It maintains rigorous quality systems and holds various regulatory certifications, ensuring compliance with international standards in product performance and safety.

Headquartered in Salt Lake City, Utah, Varex Imaging serves a diverse customer base spanning the Americas, Europe, the Middle East and Asia Pacific. The company is led by President and Chief Executive Officer Brett Wall and supported by a seasoned management team with deep experience in imaging technology and global operations. Varex Imaging remains committed to innovation, collaborating closely with OEM partners to advance the future of X-ray imaging.

Key Stats

• Today's Range: $11.32 to $11.65
• 50-Day Range: $10.34 to $13.64
• 52-Week Range: $6.76 to $14.56
• Volume: 205,455 shs
• Average Volume: 263,979 shs
• Market Capitalization: $483.11 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $16.17
• Consensus Rating: Moderate Buy

Varex Imaging Stock Analysis - MarketRank™

Varex Imaging scored higher than 80% of companies evaluated by MarketBeat, and ranked 117th out of 856 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.9 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Varex Imaging has received a consensus rating of Moderate Buy. The company's average rating score is 2.60, and is based on 1 strong buy rating, 2 buy ratings, 1 hold rating, and 1 sell rating.

Upside Potential

Varex Imaging has a consensus price target of $16.17, representing about 40.2% upside from its current price of $11.53.

Amount of Analyst Coverage

Varex Imaging has only been the subject of 3 research reports in the past 90 days.

Earnings and Valuation

• Score: 2.5 / 5
• Proj. Earnings Growth: 18.28%

Earnings Growth

Earnings for Varex Imaging are expected to grow by 18.28% in the coming year, from $0.93 to $1.10 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Varex Imaging is -7.03, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Varex Imaging is -7.03, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Varex Imaging has a P/B Ratio of 0.98. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

3.44% of the float of Varex Imaging has been sold short.

Short Interest Ratio / Days to Cover

Varex Imaging has a short interest ratio ("days to cover") of 6.42.

Change versus previous month

Short interest in Varex Imaging has recently increased by 1.12%, indicating that investor sentiment is decreasing.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Varex Imaging does not currently pay a dividend.

Dividend Growth

Varex Imaging does not have a long track record of dividend growth.

News and Social Media

• Score: 3.7 / 5
• News Sentiment: 0.89

News Sentiment

Varex Imaging has a news sentiment score of 0.89. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.56 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 2 news articles for Varex Imaging this week, compared to 1 article on an average week.

MarketBeat Follows

1 people have added Varex Imaging to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 0.9 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Varex Imaging insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $50,241.00 in company stock.

Percentage Held by Insiders

4.60% of the stock of Varex Imaging is held by insiders.

Percentage Held by Institutions

Varex Imaging has minimal institutional ownership at this time.

VREX Stock Analysis - Frequently Asked Questions

How have VREX shares performed this year?

Varex Imaging's stock was trading at $11.65 at the start of the year. Since then, VREX shares have decreased by 1.0% and is now trading at $11.53.

How were Varex Imaging's earnings last quarter?

Varex Imaging (NASDAQ:VREX) released its quarterly earnings results on Tuesday, February, 10th. The company reported $0.19 earnings per share for the quarter, beating analysts' consensus estimates of $0.14 by $0.05. The company had revenue of $209.60 million for the quarter, compared to analyst estimates of $207.83 million. Varex Imaging had a negative net margin of 7.92% and a positive trailing twelve-month return on equity of 8.43%.
Read the conference call transcript.

Who are Varex Imaging's major shareholders?

Top institutional shareholders of Varex Imaging include Pzena Investment Management LLC (9.53%), Allspring Global Investments Holdings LLC (6.32%), Assenagon Asset Management S.A. (1.10%) and Bank of New York Mellon Corp (0.37%). Insiders that own company stock include Sunny Sanyal, Shubham Maheshwari, Jay K Kunkel and Kimberley E Honeysett.
View institutional ownership trends.

How do I buy shares of Varex Imaging?

Shares of VREX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Varex Imaging own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Varex Imaging investors own include NVIDIA (NVDA), Meta Platforms (META), Tesla (TSLA), Advanced Micro Devices (AMD), Visa (V), JPMorgan Chase & Co. (JPM) and Netflix (NFLX).

Company Calendar

• Last Earnings: 2/10/2026
• Today: 5/06/2026
• Next Earnings (Confirmed): 5/07/2026
• Fiscal Year End: 9/30/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MED PRODUCTS
• Sub-Industry: Electronic Equipment
• Current Symbol: NASDAQ:VREX
• CIK: 1681622
• Web: www.vareximaging.com
• Phone: (801) 972-5000
• Fax: N/A
• Employees: 2,400
• Year Founded: 2017

Price Target and Rating

• Average Price Target for Varex Imaging: $16.17
• High Price Target: $18.00
• Low Price Target: $14.50
• Potential Upside/Downside: +40.2%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.60
• Research Coverage: 5 Analysts

Profitability

• EPS (Trailing Twelve Months): ($1.64)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: 12.40
• P/E Growth: N/A
• Net Income: -$70.30 million
• Net Margins: -7.92%
• Pretax Margin: -6.78%
• Return on Equity: 8.43%
• Return on Assets: 3.66%

Debt

• Debt-to-Equity Ratio: 0.75
• Current Ratio: 3.89
• Quick Ratio: 1.87

Sales & Book Value

• Annual Sales: $844.60 million
• Price / Sales: 0.57
• Cash Flow: $3.86 per share
• Price / Cash Flow: 2.99
• Book Value: $11.73 per share
• Price / Book: 0.98

Miscellaneous

• Outstanding Shares: 41,900,000
• Free Float: 39,973,000
• Market Cap: $483.11 million
• Optionable: Optionable
• Beta: 0.96